Hui CK - Search Results

1

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK, Hall J, Lai CL. Wong DK, et al. Among authors: hui ck. Hepatology. 2004 Sep;40(3):727-37. doi: 10.1002/hep.20353. Hepatology. 2004. PMID: 15349913

2

Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.

Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, Cheung SK, Wong WM, Lau GK; Hong Kong Liver Fibrosis Study Group. Hui CK, et al. Hepatology. 2007 Aug;46(2):395-401. doi: 10.1002/hep.21724. Hepatology. 2007. PMID: 17628874

3

Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy.

Hui CK, Bowden S, Jackson K, Au WY, Fong DY, Lie AK, Chim CS, Liang R, Lau GK. Hui CK, et al. Blood. 2005 Mar 15;105(6):2616-7. doi: 10.1182/blood-2004-09-3402. Blood. 2005. PMID: 15746088 Free article. No abstract available.

4

A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation.

Hui CK, Lie A, Au WY, Leung YH, Ma SY, Cheung WW, Zhang HY, Chim CS, Kwong YL, Liang R, Lau GK. Hui CK, et al. Blood. 2005 Jul 15;106(2):464-9. doi: 10.1182/blood-2005-02-0698. Epub 2005 Mar 29. Blood. 2005. PMID: 15797991 Free article.

5

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

Hui CK, Sun J, Au WY, Lie AK, Yueng YH, Zhang HY, Lee NP, Hou JL, Liang R, Lau GK. Hui CK, et al. J Hepatol. 2005 Jun;42(6):813-9. doi: 10.1016/j.jhep.2005.01.018. Epub 2005 Mar 31. J Hepatol. 2005. PMID: 15885351

6

Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.

Yuen MF, Wong DK, Sablon E, Yuan HJ, Sum SM, Hui CK, Chan AO, Wang BC, Lai CL. Yuen MF, et al. Among authors: hui ck. Antivir Ther. 2003 Dec;8(6):531-4. Antivir Ther. 2003. PMID: 14760886

7

A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase.

Hui CK, Belaye T, Montegrande K, Wright TL. Hui CK, et al. J Hepatol. 2003 Apr;38(4):511-7. doi: 10.1016/s0168-8278(03)00004-7. J Hepatol. 2003. PMID: 12663245

8

Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.

Hui CK, Leung N, Shek WH, Zhang HY, Luk JM, Poon RT, Lo CM, Fan ST, Lau GK; Hong Kong Liver Fibrosis Study Group. Hui CK, et al. J Clin Gastroenterol. 2008 May-Jun;42(5):533-8. doi: 10.1097/MCG.0b013e31804bbdff. J Clin Gastroenterol. 2008. PMID: 18344885

9

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

Chen Y, Lin MC, Yao H, Wang H, Zhang AQ, Yu J, Hui CK, Lau GK, He ML, Sung J, Kung HF. Chen Y, et al. Among authors: hui ck. Hepatology. 2007 Jul;46(1):200-8. doi: 10.1002/hep.21668. Hepatology. 2007. PMID: 17596871

10

Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.

Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, Lu L, Leung N, Lo CM, Fan ST, Luk JM, Xu A, Lam KS, Kwong YL, Lau GK; Hong Kong Liver Fibrosis Study Group. Hui CK, et al. J Hepatol. 2007 Aug;47(2):191-202. doi: 10.1016/j.jhep.2007.02.023. Epub 2007 Apr 12. J Hepatol. 2007. PMID: 17462782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results